{
    "organizations": [],
    "uuid": "4242e8897f519cc2a66c97cd1c9c1778b852789c",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-scynexis-inc-presents-new-in-vivo/brief-scynexis-inc-presents-new-in-vivo-data-highlighting-the-potential-of-scy-078-idUSFWN1PR10K",
    "ord_in_thread": 0,
    "title": "BRIEF-Scynexis Inc Presents New In Vivo Data Highlighting The Potential Of Scy-078",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 1 (Reuters) - Scynexis Inc:\n* SCYNEXIS PRESENTS NEW IN VIVO DATA HIGHLIGHTING THE POTENTIAL OF SCY-078 USED IN COMBINATION FOR THE TREATMENT OF ASPERGILLUS INFECTIONS AT AAA 2018 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-01T21:52:00.000+02:00",
    "crawled": "2018-02-02T12:38:09.005+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "scynexis",
        "inc",
        "scynexis",
        "present",
        "new",
        "vivo",
        "data",
        "highlighting",
        "potential",
        "used",
        "combination",
        "treatment",
        "aspergillus",
        "infection",
        "aaa",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}